ask="0.1750"
ask_size="3800"
average_daily_volume="3916540"
bid="0.1500"
bid_size="3700"
book_value="0.1040"
change="-0.0012"
change_from_200_day_moving_average="-0.0548"
change_from_50_day_moving_average="-0.0178"
change_from_52_week_high="-0.4767"
change_From_52_week_low="0.0083"
change_in_percent="-0.7295%"
close="0.1633"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6780"
ebitda="-16.86M"
eps_estimate_current_year="-0.6200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="0.1700"
ex_dividend_date="N/A"
float_shares="125385000"
high="0.1687"
high_52_weeks="0.6400"
last_trade_date="3/15/2017"
last_trade_price="0.1633"
last_trade_size="8525"
last_trade_time="4:00pm"
low="0.1550"
low_52_weeks="0.1550"
market_capitalization="21.44M"
moving_average_200_day="0.2181"
moving_average_50_day="0.1811"
name="Immune Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="4.0000"
open="0.1685"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-25.1268%"
percent_change_from_50_day_moving_average="-9.8502%"
percent_change_from_52_week_high="-74.4844%"
percent_change_from_52_week_low="+5.3548%"
previous_close="0.1645"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.5817"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="131291000"
short_ratio="2.7700"
stock_exchange="NCM"
symbol="IMNP"
volume="1810356"
weeks_range_52="0.1550 - 0.6400"
